<DOC>
	<DOCNO>NCT02989467</DOCNO>
	<brief_summary>This research study do compare effect Aprepitant placebo fast gastric volume , accommodation volume , satiation ( fullness ) gastric empty .</brief_summary>
	<brief_title>Effects Aprepitant Satiation , Gastric Volume , Gastric Accommodation Gastric Emptying</brief_title>
	<detailed_description />
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Inclusion criterion : 1 . Able provide write consent 2 . No medical problem chronic disease , specifically , type 2 diabetes mellitus 3 . Body Mass Index 1835 kg/m^2 4 . Female subject must negative urine pregnancy test must lactate prior receive study medication radiation exposure 5 . For female able bear child , hormonal ( i.e. , oral , implantable , injectable ) singlebarrier method , doublebarrier method birth control must use throughout study 6 . Female subject unable bear child must document medical record ( i.e. , tubal ligation , hysterectomy , postmenopausal [ define minimum one year since last menstrual period ] ) Exclusion criterion : 1 . Diagnosis gastrointestinal disease 2 . Structural metabolic disease affect gastrointestinal system 3 . Unable avoid follow overthecounter medication 48 hour prior baseline period throughout study : Medications alter GI transit include laxative , magnesium aluminum contain antacid , prokinetics , erythromycin Analgesic drug include NSAIDs cyclooxygenase2 ( COX2 ) inhibitor . ( NOTE : Stable dos thyroid replacement , estrogen replacement , lowdose aspirin cardioprotection , birth control ( adequate backup contraception druginteractions birth control conduct ) permissible . ) 4 . History recent surgery ( within 60 day screen ) . 5 . Acute chronic illness history illness , opinion investigator could pose threat harm subject obscure interpretation laboratory test result interpretation study data frequent angina , Class III IV congestive heart failure , moderate impairment renal hepatic function , poorly control diabetes , etc . 6 . Any clinically significant abnormality physical examination laboratory abnormality identify medical record , determine investigator . 7 . Acute GI illness within 48 hour initiation baseline period . 8 . Females pregnant breastfeeding . 9 . History excessive alcohol use substance abuse . 10 . Participation investigational study within 30 day prior dose present study . 11 . Any reason , opinion investigator would confound proper interpretation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>